159 related articles for article (PubMed ID: 10784130)
1. Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke.
Kano T; Katayama Y; Tejima E; Lo EH
Brain Res; 2000 Jan; 854(1-2):245-8. PubMed ID: 10784130
[TBL] [Abstract][Full Text] [Related]
2. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation After Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke.
García-Culebras A; Palma-Tortosa S; Moraga A; García-Yébenes I; Durán-Laforet V; Cuartero MI; de la Parra J; Barrios-Muñoz AL; Díaz-Guzmán J; Pradillo JM; Moro MA; Lizasoain I
Stroke; 2017 Jun; 48(6):1695-1699. PubMed ID: 28428349
[TBL] [Abstract][Full Text] [Related]
4. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Won S; Lee JH; Wali B; Stein DG; Sayeed I
J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
[TBL] [Abstract][Full Text] [Related]
5. Extension of the thrombolytic time window with minocycline in experimental stroke.
Murata Y; Rosell A; Scannevin RH; Rhodes KJ; Wang X; Lo EH
Stroke; 2008 Dec; 39(12):3372-7. PubMed ID: 18927459
[TBL] [Abstract][Full Text] [Related]
6. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
[TBL] [Abstract][Full Text] [Related]
7. Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator.
Rodríguez-González R; Blanco M; Rodríguez-Yáñez M; Moldes O; Castillo J; Sobrino T
Atherosclerosis; 2013 Jan; 226(1):165-71. PubMed ID: 23218119
[TBL] [Abstract][Full Text] [Related]
8. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Liu KJ
Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
[TBL] [Abstract][Full Text] [Related]
9. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice.
García-Yébenes I; García-Culebras A; Peña-Martínez C; Fernández-López D; Díaz-Guzmán J; Negredo P; Avendaño C; Castellanos M; Gasull T; Dávalos A; Moro MA; Lizasoain I
Stroke; 2018 Sep; 49(9):2163-2172. PubMed ID: 30018160
[TBL] [Abstract][Full Text] [Related]
10. Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke.
Dela Peña IC; Yang S; Shen G; Fang Liang H; Solak S; Borlongan CV
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857523
[TBL] [Abstract][Full Text] [Related]
11. Hemorrhagic transformation after fibrinolysis with tissue plasminogen activator: evaluation of role of hypertension with rat thromboembolic stroke model.
Tejima E; Katayama Y; Suzuki Y; Kano T; Lo EH
Stroke; 2001 Jun; 32(6):1336-40. PubMed ID: 11387496
[TBL] [Abstract][Full Text] [Related]
12. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
Lapchak PA; Araujo DM; Song D; Zivin JA
Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
Lapchak PA; Chapman DF; Zivin JA
Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
[TBL] [Abstract][Full Text] [Related]
14. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
Zuo W; Chen J; Zhang S; Tang J; Liu H; Zhang D; Chen N
Eur J Neurosci; 2014 Jun; 39(12):2107-18. PubMed ID: 24649933
[TBL] [Abstract][Full Text] [Related]
15. NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic stroke.
Merino-Zamorano C; Hernández-Guillamon M; Jullienne A; Le Béhot A; Bardou I; Parés M; Fernández-Cadenas I; Giralt D; Carrera C; Ribó M; Vivien D; Ali C; Rosell A; Montaner J
Stroke; 2015 Feb; 46(2):477-84. PubMed ID: 25503547
[TBL] [Abstract][Full Text] [Related]
16. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
Liu H; Wang Y; Xiao Y; Hua Z; Cheng J; Jia J
Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
[TBL] [Abstract][Full Text] [Related]
18. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
Lapchak PA; Chapman DF; Zivin JA
Stroke; 2000 Dec; 31(12):3034-40. PubMed ID: 11108768
[TBL] [Abstract][Full Text] [Related]
19. New appearance of extraischemic microbleeds on T2*-weighted magnetic resonance imaging 24 hours after tissue-type plasminogen activator administration.
Kimura K; Aoki J; Shibazaki K; Saji N; Uemura J; Sakamoto Y
Stroke; 2013 Oct; 44(10):2776-81. PubMed ID: 23887835
[TBL] [Abstract][Full Text] [Related]
20. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
